Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Cancer Chemotherapy and Pharmacology|December 4, 2013
First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancerMuhammad Wasif Saif, Jia Li, Lynne Lamb, et al.Anticancer Research|October 23, 2009
Phase I/II study of PHY906/capecitabine in advanced hepatocellular carcinomaYun Yen, Samuel So, Michal Rose, et al.Water Environment Research : a Research Publication of the Water Environment Federation|September 29, 2017
Chemical Waste and Allied ProductsYung-Tse Hung, Hamidi Abdul Aziz, Sharifah Farah Fariza Syed Zainal, et al.Scientific Reports|March 31, 2015
PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironmentWing Lam, Zaoli Jiang, Fulan Guan, et al.Water Environment Research : a Research Publication of the Water Environment Federation|August 22, 2018
Chemical Waste and Allied ProductsYung-Tse Hung, Hamidi Abdul Aziz, Sharifah Farah Fariza Syed Zainal, et al.Water Environment Research : a Research Publication of the Water Environment Federation|October 1, 2015
Chemical Waste and Allied ProductsYung-Tse Hung, Hamidi Abdul Aziz, Mohd Suffian Yusoff, et al.Biomedicines|July 2, 2021
PI3K and MAPK Pathways as Targets for Combination with the Pan-HER Irreversible Inhibitor Neratinib in HER2-Positive Breast Cancer and TNBC by Kinome RNAi ScreeningJangsoon Lee, Huey Liu, Troy Pearson, et al.Chinese Medicine|August 24, 2010
A comprehensive platform for quality control of botanical drugs (PhytomicsQC): a case study of Huangqin Tang (HQT) and PHY906Robert Tilton, Anthony A Paiva, Jing-Qu Guan, et al.Clinical Colorectal Cancer|August 24, 2011
A phase I study of the chinese herbal medicine PHY906 as a modulator of irinotecan-based chemotherapy in patients with advanced colorectal cancerShivaani Kummar, M Sitki Copur, Michal Rose, et al.Journal of Gastrointestinal Oncology|July 11, 2024
A single arm phase 2 clinical trial of YIV-906 with neoadjuvant concurrent chemo-radiation therapy in patients with locally advanced rectal cancerNipun Verma, Kimberly L Johung, Jeremy Kortmansky, et al.Pageof 4